HIV vaccine candidate has shown to generate more than 80% protection in groups of twelve female monkeys against high dose, repeated AIDS virus exposures during part of a preclinical study.
12-Apr-2016 10:30 AM EDT Add to Favorites
A recent study published in the November issue of the journal Aging showed minimal metabolic side effects after continuous, long-term treatment with encapsulated rapamycin in a marmoset (monkey) model. Research results lead to efficacy study.
9-Feb-2016 10:00 AM EST Add to Favorites
In a Journal of Virology paper, Texas Biomed Scientist Dr. Anthony Griffiths, explains how he and his team found that Ebola virus has the potential to evolve rapidly but the genetic changes result in viruses that are weakened or not viable, which...
5-Jan-2016 10:00 AM EST Add to Favorites
The National Institutes of Health have awarded scientists at Texas Biomedical Research Institute and collaborators at the Food and Drug Administration, UCLA and the University of Pennsylvania a $5 million grant over the next 4 years to study a...
3-Dec-2015 10:00 AM EST Add to Favorites
Texas Biomedical Research Institute and Wisconsin-based non-profit Take Off Pounds Sensibly® are establishing the new TOPS® Nutrition and Obesity Research Center with the goal of conducting research into the causes, health risks and treatment of...
26-Jun-2015 7:30 AM EDT Add to Favorites
Texas Biomed Scientist Receives Nearly $3.4 Million NIH Grant to Study Papillomavirus-Based AIDS Vaccine for Dual Protection Against HIV and HPV-Induced Cancer
Scientists at Texas Biomedical Research Institute have begun work on a study funded by the National Institutes of Health over the next four years to create an attenuated, or weakened, virus that is a hybrid of the papilloma virus and the human...
30-Apr-2015 9:45 AM EDT Add to Favorites
Texas Biomed Scientist Receives Up to $2.36 Million NIH Grant Over 5 Years to Study New Virus Detection Methods
Scientists at Texas Biomedical Research Institute in San Antonio are receiving funding from the National Institutes of Health in the form of a $2.36 million R01 grant over the next five years to focus efforts on exploring and developing a novel...
9-Apr-2015 10:30 AM EDT Add to Favorites
New research that focuses on the mechanism by which Ebola virus infects a cell and the discovery of a promising drug therapy candidate is being published February 27, 2015, in the journal Science.
25-Feb-2015 2:00 PM EST Add to Favorites